Hyman Charles D Bristol Myers Squibb CO Transaction History

Hyman Charles D

$1.79 Billion
Q2 2024

A detailed history of Hyman Charles D transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hyman Charles D holds 190,354 shares of BMY stock, worth $10.8 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

190,354

Previous 200,289 4.96%

Holding current value

$10.8 Million

Previous $10.9 Million 27.22%

% of portfolio

0.44%

Previous 0.6%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$40.25 - $52.99 $399,883 - $526,455	-9,935 Reduced 4.96%	190,354 $7.91 Million
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $102,437 - $116,144	-2,135 Reduced 1.05%	200,289 $10.9 Million
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $739,077 - $881,923	-15,245 Reduced 7.0%	202,424 $10.4 Million
Q3 2023 Nov 01, 2023	SELL	$57.89 - $64.73 $17,367 - $19,419	-300 Reduced 0.14%	217,669 $12.6 Million
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $6,371 - $7,073	100 Added 0.05%	217,969 $13.9 Million
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $88,708 - $100,615	-1,350 Reduced 0.62%	217,869 $15.1 Million
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $51,565 - $61,060	-753 Reduced 0.34%	219,219 $15.8 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $419 - $247,885	-3,226 Reduced 1.45%	219,972 $15.6 Million
Q2 2022 Aug 02, 2022	BUY	$72.62 - $79.98 $61,727 - $67,983	850 Added 0.38%	223,198 $17.2 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $946,546 - $1.13 Million	15,396 Added 7.44%	222,348 $16.2 Million
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $10,511 - $12,253	-196 Reduced 0.09%	206,952 $12.9 Million
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $163,013 - $190,949	-2,755 Reduced 1.31%	207,148 $12.3 Million
Q2 2021 Aug 05, 2021	SELL	$61.91 - $67.42 $216,127 - $235,363	-3,491 Reduced 1.64%	209,903 $14 Million
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $49,598 - $56,204	859 Added 0.4%	213,394 $13.2 Million
Q3 2020 Oct 26, 2020	SELL	$57.43 - $63.64 $250,911 - $278,043	-4,369 Reduced 2.01%	212,535 $12.8 Million
Q2 2020 Aug 06, 2020	BUY	$54.82 - $64.09 $1.57 Million - $1.83 Million	28,569 Added 15.17%	216,904 $12.8 Million
Q1 2020 Apr 30, 2020	SELL	$46.4 - $67.43 $93,588 - $136,006	-2,017 Reduced 1.06%	188,335 $10.5 Million
Q4 2019 Feb 03, 2020	BUY	$49.21 - $64.19 $44,633 - $58,220	907 Added 0.48%	190,352 $12.2 Million
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $72,709 - $86,207	-1,700 Reduced 0.89%	189,445 $9.61 Million
Q2 2019 Jul 24, 2019	BUY	$44.62 - $49.34 $10,262 - $11,348	230 Added 0.12%	191,145 $8.67 Million
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $290,527 - $346,418	6,439 Added 3.49%	190,915 $9.11 Million
Q4 2018 Jan 31, 2019	SELL	$48.76 - $63.23 $37,545 - $48,687	-770 Reduced 0.42%	184,476 $9.59 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $65,952 - $74,388	-1,195 Reduced 0.64%	185,246 $11.5 Million
Q2 2018 Aug 06, 2018	BUY	$50.53 - $62.98 $78,068 - $97,304	1,545 Added 0.84%	186,441 $10.3 Million
Q1 2018 May 07, 2018	SELL	$59.92 - $68.98 $52,430 - $60,357	-875 Reduced 0.47%	184,896 $11.7 Million
Q4 2017 Feb 06, 2018	SELL	$59.94 - $65.35 $512,846 - $559,134	-8,556 Reduced 4.4%	185,771 $11.4 Million
Q3 2017 Nov 13, 2017	SELL	$55.23 - $63.74 $116,093 - $133,981	-2,102 Reduced 1.07%	194,327 $12.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	196,429	196,429 $10.9 Million

Others Institutions Holding BMY

# of Institutions

2,535

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

News

Stay updated on Hyman Charles D with notifications on news.

Account